Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure and Function of Platelets01:18

Structure and Function of Platelets

2.4K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
2.4K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

8.1K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.1K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

838
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
838
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

1.2K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.2K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

3.2K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human Development Index and outcomes in older critically ill patients: A European multicentre study.

Annals of intensive care·2026
Same author

The Potential for Combined Treponemal/Nontreponemal Rapid Point-of-Care Test and Treponema pallidum Polymerase Chain Reaction in the Diagnosis of Gestational and Congenital Syphilis in a Low-Resource, High-Prevalence Setting: Pilot Data From Malawi.

Sexually transmitted diseases·2026
Same author

A prematurely terminated phase 2, randomised trial to evaluate immunogenicity and reactogenicity of a single versus two-dose primary vaccination regimen of the mRNA vaccine BNT162b2 in previously SARS-CoV-2 infected children 5-11 years old (CoVacc trial).

Vaccine·2026
Same author

Beyond echocardiography: rethinking postpulmonary embolism follow-up in light of European Society of Cardiology algorithms.

Journal of thrombosis and haemostasis : JTH·2026
Same author

Refining inflammatory profiles linked to cardiometabolic outcomes in people with HIV using recursive feature addition modelling.

Clinical and translational medicine·2026
Same author

Sex and 30-day mortality in elderly critically Ill adults: A frailty-adjusted multinational analysis with frequentist and bayesian estimates.

European journal of internal medicine·2026
Same journal

Sequential neural dynamics underlie unconscious integration and conscious perception of visual stimuli.

PLoS biology·2026
Same journal

Engineering resilient gene drives for sustainable malaria control by predicting, testing and overcoming target site resistance in Anopheles gambiae.

PLoS biology·2026
Same journal

Shared memories of event details in the human brain are altered by misinformation and test expectations.

PLoS biology·2026
Same journal

Resistance potentiators: Evolutionary catalysts of antibiotic resistance.

PLoS biology·2026
Same journal

The cell cloud: Adopting systems biology concepts in the era of single-cell immunology.

PLoS biology·2026
Same journal

Disinhibitory signaling enables flexible coding of top-down information in cortical networks.

PLoS biology·2026
See all related articles

Related Experiment Video

Updated: Nov 17, 2025

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

853

COVID-19 induces a hyperactive phenotype in circulating platelets.

Shane P Comer1,2, Sarah Cullivan3, Paulina B Szklanna1,2

  • 1Conway SPHERE Research Group, Conway Institute, University College Dublin, Dublin Ireland.

Plos Biology
|February 17, 2021
PubMed
Summary
This summary is machine-generated.

COVID-19 patients exhibit heightened platelet activity and altered blood parameters, including increased mean platelet volume. These findings suggest abnormal platelet reactivity contributes to hypercoagulability and disease severity in Coronavirus Disease 2019.

More Related Videos

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry
08:04

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry

Published on: June 10, 2025

863
Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
05:49

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

Published on: November 29, 2024

933

Related Experiment Videos

Last Updated: Nov 17, 2025

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

853
Analyzing Platelet Subpopulations by Multi-color Flow Cytometry
08:04

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry

Published on: June 10, 2025

863
Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
05:49

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

Published on: November 29, 2024

933

Area of Science:

  • Hematology
  • Virology
  • Immunology

Background:

  • Coronavirus Disease 2019 (COVID-19) is linked to increased venous thromboembolism and endothelial dysfunction.
  • The exact causes of heightened thrombotic risk in COVID-19 remain unclear.

Purpose of the Study:

  • To investigate clinical platelet parameters and circulating platelet activity in patients with severe and non-severe COVID-19.
  • To correlate these parameters with disease severity and hospital outcomes.

Main Methods:

  • Analysis of clinical blood parameters in severe COVID-19, non-severe COVID-19, general medical patients, and healthy donors.
  • Assessment of platelet function, including agonist-induced adenosine diphosphate (ADP) release.
  • Measurement of circulating platelet activation markers: platelet factor 4 (PF4), soluble P-selectin (sP-selectin), and thrombopoietin (TPO).

Main Results:

  • Increased mean platelet volume (MPV) and decreased platelet:neutrophil ratio are associated with COVID-19 severity and intensive care unit (ICU) admission.
  • COVID-19 patients displayed significantly higher agonist-induced ADP release (30-90 fold) compared to controls.
  • Elevated circulating levels of PF4, sP-selectin, and TPO were observed in COVID-19 patients.

Conclusions:

  • Distinct differences in full blood count and clinical laboratory parameters distinguish severe from non-severe COVID-19.
  • All COVID-19 patients studied exhibited hyperactive circulating platelets.
  • Abnormal platelet reactivity likely contributes to hypercoagulability, influencing COVID-19 severity and recovery.